← Evidence map

ArticleBlood advances2023

Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma.

Julia Driessen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2023
2024
2025
2026
this papertrialcites it

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 37722357